Jinhai Medical Technology Limited (HKG:2225)
Hong Kong
· Delayed Price · Currency is HKD 4.160
-0.240 (-5.45%)
Apr 29, 2026, 3:06 PM HKT
Jinhai Medical Technology Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 46.28 | 50.24 | 45.64 | 22.28 | 21.9 | Upgrade
|
| Revenue Growth (YoY) | -7.89% | 10.07% | 104.87% | 1.75% | -2.56% | Upgrade
|
| Cost of Revenue | 39.09 | 38.76 | 33.62 | 12.16 | 14.17 | Upgrade
|
| Gross Profit | 7.19 | 11.48 | 12.03 | 10.12 | 7.73 | Upgrade
|
| Selling, General & Admin | 25.02 | 31.95 | 15.95 | 10.25 | 8.71 | Upgrade
|
| Operating Expenses | 25.2 | 31.57 | 16.62 | 10.12 | 9.16 | Upgrade
|
| Operating Income | -18.01 | -20.09 | -4.59 | - | -1.43 | Upgrade
|
| Interest Expense | -0.68 | -0.77 | -0.22 | -0.09 | -0.13 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.29 | 0.36 | 0.45 | 0.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.28 | 0.28 | -0.63 | 0.11 | 0.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.1 | 1.46 | 2.8 | 0.55 | 0.19 | Upgrade
|
| EBT Excluding Unusual Items | -17.8 | -18.83 | -2.29 | 1.03 | -1.02 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.5 | 0.23 | -1.02 | -0.89 | -0.81 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | 0.02 | -0.02 | 0.15 | 0.28 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.08 | Upgrade
|
| Other Unusual Items | - | 0.17 | 0.01 | 0.32 | 1.49 | Upgrade
|
| Pretax Income | -17.16 | -18.23 | -3.22 | 0.78 | -0.06 | Upgrade
|
| Income Tax Expense | 0.23 | 0.03 | 0.9 | 0.67 | 0.44 | Upgrade
|
| Earnings From Continuing Operations | -17.4 | -18.26 | -4.11 | 0.12 | -0.5 | Upgrade
|
| Minority Interest in Earnings | 0.32 | 0.29 | 0.97 | 0.35 | 0.25 | Upgrade
|
| Net Income | -17.08 | -17.97 | -3.14 | 0.47 | -0.25 | Upgrade
|
| Net Income to Common | -17.08 | -17.97 | -3.14 | 0.47 | -0.25 | Upgrade
|
| Shares Outstanding (Basic) | 5,216 | 5,170 | 4,971 | 4,920 | 4,920 | Upgrade
|
| Shares Outstanding (Diluted) | 5,216 | 5,170 | 4,971 | 4,920 | 4,920 | Upgrade
|
| Shares Change (YoY) | 0.88% | 4.00% | 1.04% | - | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| Free Cash Flow | - | -4.26 | -3.15 | 3.06 | 2.73 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | -0.00 | 0.00 | 0.00 | Upgrade
|
| Gross Margin | 15.53% | 22.84% | 26.35% | 45.40% | 35.29% | Upgrade
|
| Operating Margin | -38.92% | -39.98% | -10.06% | - | -6.55% | Upgrade
|
| Profit Margin | -36.91% | -35.76% | -6.88% | 2.10% | -1.12% | Upgrade
|
| Free Cash Flow Margin | - | -8.49% | -6.89% | 13.75% | 12.48% | Upgrade
|
| EBITDA | -14.21 | -16.29 | -1.33 | 3.57 | 2.33 | Upgrade
|
| EBITDA Margin | -30.70% | -32.42% | -2.90% | 16.03% | 10.63% | Upgrade
|
| D&A For EBITDA | 3.8 | 3.8 | 3.27 | 3.57 | 3.76 | Upgrade
|
| EBIT | -18.01 | -20.09 | -4.59 | - | -1.43 | Upgrade
|
| EBIT Margin | -38.92% | -39.98% | -10.06% | - | -6.55% | Upgrade
|
| Effective Tax Rate | - | - | - | 85.20% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.